National Institute of Agrobiological Sciences, Others Confirm Allergy Alleviating Effect of Transgenic Rice.
First, NIAS has genetically modified rice in collaboration with the Institute of Medical Science of the University of Tokyo and Shimane University. The transgenic rice has an endosperm, which specifically accumulates T-cell epitope peptide, a kind of cedar pollen antigen.
Then, the three partners have assayed the rice's effectiveness in mice experiments. The experiment results indicated that an oral administration of rice helps alleviate allergic symptoms, in particular, sneezing.
Accordingly, the joint research group has concluded that the transgenic rice has a property to effectively induce oral immune tolerance. These findings will be featured in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) issued on October 31.
Going forward, NIAS will strive to verify the safety and effectiveness of the transgenic rice through collaboration with medical professionals. Specifically, it plans to carry out basic and clinical researches on monkeys and humans.
Source: JCN http://www.japancorp.net
Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Nov 2, 2005|
|Previous Article:||Itochu, US Bio Venture Peptimmune to Form Capital and Business Alliance.|
|Next Article:||Interwired Announces Results of Survey on Humidifiers.|